Transcatheter Aortic Valve Replacement: What's in a Name?

According to William Shakespeare, "That which we call a rose; by any other name would still smell as sweet" (Romeo and Juliette, c. 1597). With commercial release of the Sapien valve on November 2, 2011, the TAVR misnomer was memorialized: "The U.S. FDA today approved the first artifi...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2012-07, Vol.60 (3), p.239-239
Main Authors: Clegg, Stacey D., MD, Krantz, Mori J., MD
Format: Article
Language:English
Subjects:
Aortic Valve - surgery
Cardiology
Cardiovascular
Coronary vessels
Endovascular Procedures
Heart
Heart Valve Prosthesis Implantation - methods
Humans
Internal Medicine
Terminology as Topic
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:According to William Shakespeare, "That which we call a rose; by any other name would still smell as sweet" (Romeo and Juliette, c. 1597). With commercial release of the Sapien valve on November 2, 2011, the TAVR misnomer was memorialized: "The U.S. FDA today approved the first artificial heart valve that can replace an aortic heart valve damaged by senile aortic valve stenosis without open-heart surgery" (3).
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2012.03.049